EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Neuroptix Raises $4.6M

Xconomy Boston — 

Neuroptix, an Acton, MA-based developer of a diagnostic test for Alzheimer’s disease, has raised $4.6 million of a mixed offering of equity and rights that could total $9.1 million, according to an SEC filing. The company brought in $18.5 million in a Series B round of funding in 2008, led by Inventages.